Center for Social Innovation, Massachusetts

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Center for Social Innovation, Massachusetts sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 9 completed early-phase tilt top decile by trial count

Center for Social Innovation, Massachusetts: 9 sponsored US clinical trials, none currently recruiting.

Center for Social Innovation, Massachusetts sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 0 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Psychosis, with 2 trials.

Top-decile sponsor footprint

Center for Social Innovation, Massachusetts ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED Phase 1

Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment

NCT06266572
COMPLETED NA

OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis

NCT03390491
COMPLETED NA

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care

NCT03465371
COMPLETED NA

Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and Clinicians

NCT03053557
COMPLETED NA

Recovery Roadmap Phase II Small Business Innovation Research Grant

NCT02707367
COMPLETED NA

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care

NCT02933567
COMPLETED NA

Phase II Motivational Interviewing: An Experiential Online Training Tool

NCT02264327
COMPLETED Phase 1

OnTrack>An Online Role-Playing Game: A Small Business Innovation Research (SBIR) Grant

NCT02415764
COMPLETED Phase 2

Implementation, Fidelity, and Outcomes Following Novel and Usual Critical Time Intervention Training

NCT02427022

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 1

Therapeutic Areas

Psychosis 2

How the Center for Social Innovation, Massachusetts early-phase archive is shaped

9 indexed studies, none listed as recruiting (0% open); 9 completed (100%).

Phase mix: 0 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Psychosis (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Center for Social Innovation, Massachusetts: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Center for Social Innovation, Massachusetts sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share Center for Social Innovation, Massachusetts4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi company10xBio22nd Century Group23andMe3-C Institute for Social Development
Center for Social Innovation, Massachusetts sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Center for Social Innovation, Massachusetts sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Center for Social Innovation, Massachusetts page

9 registered trials is a research-attention snapshot, not an endorsement of Center for Social Innovation, Massachusetts or any single study.

  • None of Center for Social Innovation, Massachusetts's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Psychosis is the condition Center for Social Innovation, Massachusetts studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Psychosis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Center for Social Innovation, Massachusetts pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.